國立虎尾科技大學 |

Maternal Drug Use and Infant Congenital Malformations

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Maternal Drug Use and Infant Congenital Malformations/ by Bengt Källén.
Author:	Källén, Bengt.
Description:	XVIII, 425 p. 16 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Obstetrics. -
Online resource:	https://doi.org/10.1007/978-3-030-17898-7
ISBN:	9783030178987

Maternal Drug Use and Infant Congenital Malformations
Källén, Bengt.

Maternal Drug Use and Infant Congenital Malformations[electronic resource] /by Bengt Källén. - 1st ed. 2019. - XVIII, 425 p. 16 illus. in color.online resource.

Background -- Maternal use of antacids or drugs for GERD and infant congenital malformations -- Maternal use of drugs for intestinal problems, except intestinal inflammations, and infant congenital malformations -- Maternal use of drugs for inflammatory intestinal disease and infant congenital malformations -- Maternal use of anti-obesity drugs and infant congenital malformations -- Maternal use of insulin or oral hypoglycemic drugs and infant congenital malformations.-Maternal use of vitamins and infant congenital malformations.-Maternal use of anticoagulants and hemostatic drugs and infant congenital malformations.-Maternal use of drugs for cardiovascular diseases and infant congenital malformations.-Maternal use of dermatological drugs and infant congenital malformations -- Maternal use of prolactin inhibitors or sex hormones and infant congenital malformations -- Maternal use of drugs for thyroid disease and infant congenital malformations -- Maternal systemic use of corticosteroids and infant congenital malformations -- Maternal use of hypophyseal or hypothalamic hormones and infant congenital malformations -- Maternal use of antibacterial or antifungal drugs and infant congenital malformations.-Maternal use of antiviral drugs, immunoglobulins, or vaccines and infant congenital malformations.-Maternal use of cytostatic/cytotoxic drugs or endocrine drugs used for malignancy and infant congenital malformations -- Maternal use of immunostimulating or immunosuppressive drugs and infant congenital malformations -- Maternal use of NSAID drugs and infant congenital malformations.-Maternal use of drugs other than NSAIDs for musculoskeletal diseases and infant congenital malformations -- Maternal use of opiates or opioid analgesics and infant congenital malformations -- Maternal use of mild analgesics and infant congenital malformations -- Maternal use of drugs for migraine and infant congenital malformations -- Maternal use of anticonvulsants and infant congenital malformations.-. Maternal use of antipsychotics and infant congenital malformations -- Maternal use of sedatives or hypnotics and infant congenital malformations -- Maternal use of antidepressants and infant congenital malformations -- Maternal use of other psychoactive drugs and infant congenital malformations -- Maternal use of antiprotozoans, antihelminthics or insecticides and infant congenital malformations -- Maternal use of nasal decongestants, other nasal preparations, or throat preparations and infant congenital malformations -- Maternal use of anti-asthmatics and infant congenital malformations -- Maternal use of cough and common cold medicines and infant congenital malformations -- Maternal use of drugs for nausea and vomiting in pregnancy and infant congenital malformations -- Maternal use of antihistamine drugs for allergy and infant congenital malformations -- Maternal use of local eye and ear drug therapy and infant congenital malformations -- Maternal use of some groups of drugs with common side effects and infant congenital malformations -- The practical consequences of observed associations between the use of drug and infant congenital malformation.

This book is the combination of the literature on maternal drug use and birth defects with a set of new data on most types of drugs. In this book, for each group of drugs the relevant scientific literature on drug teratogenicity is presented, with consideration of possible sources of error and also what the findings may mean from a practical point of view. The book also adds data from the Swedish health registers for 1996-2013 based on more than 1.7 million early-pregnancy midwife interviews. Maternal Drug Use and Infant Congenital Malformations will find an engaged audience among people working within the field, and will be of interest to healthcare providers, especially obstetricians and other clinicians who treat women of childbearing age.

ISBN: 9783030178987

Standard No.: 10.1007/978-3-030-17898-7doiSubjects--Topical Terms:

674110
Obstetrics.

LC Class. No.: RG499.2-991

Dewey Class. No.: 618.2

Maternal Drug Use and Infant Congenital Malformations
LDR:05277nam a22004095i 4500 001 1013594
003 DE-He213
005 20200701090553.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030178987 $9 978-3-030-17898-7
024 7 $a 10.1007/978-3-030-17898-7 $2 doi
035 $a 978-3-030-17898-7
050 4 $a RG499.2-991
050 4 $a RG600-650
072 7 $a MJT $2 bicssc
072 7 $a MED033000 $2 bisacsh
072 7 $a MKC $2 thema
082 0 4 $a 618.2 $2 23
100 1 $a Källén, Bengt. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1272156
245 1 0 $a Maternal Drug Use and Infant Congenital Malformations $h [electronic resource] / $c by Bengt Källén.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XVIII, 425 p. 16 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Background -- Maternal use of antacids or drugs for GERD and infant congenital malformations -- Maternal use of drugs for intestinal problems, except intestinal inflammations, and infant congenital malformations -- Maternal use of drugs for inflammatory intestinal disease and infant congenital malformations -- Maternal use of anti-obesity drugs and infant congenital malformations -- Maternal use of insulin or oral hypoglycemic drugs and infant congenital malformations.-Maternal use of vitamins and infant congenital malformations.-Maternal use of anticoagulants and hemostatic drugs and infant congenital malformations.-Maternal use of drugs for cardiovascular diseases and infant congenital malformations.-Maternal use of dermatological drugs and infant congenital malformations -- Maternal use of prolactin inhibitors or sex hormones and infant congenital malformations -- Maternal use of drugs for thyroid disease and infant congenital malformations -- Maternal systemic use of corticosteroids and infant congenital malformations -- Maternal use of hypophyseal or hypothalamic hormones and infant congenital malformations -- Maternal use of antibacterial or antifungal drugs and infant congenital malformations.-Maternal use of antiviral drugs, immunoglobulins, or vaccines and infant congenital malformations.-Maternal use of cytostatic/cytotoxic drugs or endocrine drugs used for malignancy and infant congenital malformations -- Maternal use of immunostimulating or immunosuppressive drugs and infant congenital malformations -- Maternal use of NSAID drugs and infant congenital malformations.-Maternal use of drugs other than NSAIDs for musculoskeletal diseases and infant congenital malformations -- Maternal use of opiates or opioid analgesics and infant congenital malformations -- Maternal use of mild analgesics and infant congenital malformations -- Maternal use of drugs for migraine and infant congenital malformations -- Maternal use of anticonvulsants and infant congenital malformations.-. Maternal use of antipsychotics and infant congenital malformations -- Maternal use of sedatives or hypnotics and infant congenital malformations -- Maternal use of antidepressants and infant congenital malformations -- Maternal use of other psychoactive drugs and infant congenital malformations -- Maternal use of antiprotozoans, antihelminthics or insecticides and infant congenital malformations -- Maternal use of nasal decongestants, other nasal preparations, or throat preparations and infant congenital malformations -- Maternal use of anti-asthmatics and infant congenital malformations -- Maternal use of cough and common cold medicines and infant congenital malformations -- Maternal use of drugs for nausea and vomiting in pregnancy and infant congenital malformations -- Maternal use of antihistamine drugs for allergy and infant congenital malformations -- Maternal use of local eye and ear drug therapy and infant congenital malformations -- Maternal use of some groups of drugs with common side effects and infant congenital malformations -- The practical consequences of observed associations between the use of drug and infant congenital malformation.
520 $a This book is the combination of the literature on maternal drug use and birth defects with a set of new data on most types of drugs. In this book, for each group of drugs the relevant scientific literature on drug teratogenicity is presented, with consideration of possible sources of error and also what the findings may mean from a practical point of view. The book also adds data from the Swedish health registers for 1996-2013 based on more than 1.7 million early-pregnancy midwife interviews. Maternal Drug Use and Infant Congenital Malformations will find an engaged audience among people working within the field, and will be of interest to healthcare providers, especially obstetricians and other clinicians who treat women of childbearing age.
650 0 $a Obstetrics. $3 674110
650 0 $a Pharmacy. $3 582411
650 0 $a Epidemiology. $3 635923
650 0 $a Maternal and child health services. $3 1254895
650 1 4 $a Obstetrics/Perinatology/Midwifery. $3 1200342
650 2 4 $a Drug Safety and Pharmacovigilance. $3 1064651
650 2 4 $a Maternal and Child Health. $3 673786
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030178970
776 0 8 $i Printed edition: $z 9783030178994
776 0 8 $i Printed edition: $z 9783030179007
856 4 0 $u https://doi.org/10.1007/978-3-030-17898-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)